Patient engagement is a cornerstone to successful care delivery in today’s competitive, consumer-driven healthcare ecosystem and creating consistently positive patient experiences requires consistent processes.
We believe that routine patient rounding anchored by a technology interface is a very effective way to reinforce standardized workflows, gather data around specific goals and initiatives, and provide leaders with the ability to hone in on critical service area issues with robust data analytics.
In the article, Warner Thomas at Ochsner comments that patients are interested in engaging with their own health and wellness. This is very true; however, when rounding on patients and families, simply handing a patient a tablet and asking them to complete a survey is not a very engaging experience. Truly engaged patient rounding encourages conversation with care team members for more in-depth discussion, relationship-building, and making a patient and their family recognize that they are being cared for by a community of empathetic and knowledgeable individuals.
But excellent patient engagement cannot be accomplished without successful employee and leadership support. As Bob Garrett at Hackensack Meridian says, it really is all about creating a common culture and having clear communication and expectations. Howard Kern at Sentara cites a focus on constantly engaging with patients along the spectrum but also notes that his leadership team visibly supports patient experience with constant reinforcement of why patient engagement is important and by inspiring a culture that empowers employees. Our experience also shows that employee interviewing or rounding, much like patient rounding, should be established as part of the normal care-giving process. Without engaged employees, we cannot hope to have engaged patients.
Learn more about ParlaiQ’s approach to employee and patient engagement at ParlaiQ.com
A Year in Review: A comprehensive look at UPMC Enterprises 2020
Over the last year, UPMC Enterprises, our portfolio companies, and select partners have all supported UPMC’s mission of Life Changing Medicine. In the booklet below, we have compiled highlights from a truly unique year and recognize the team members and projects that have enabled our success.
Werewolf Therapeutics launches as publicly traded company
Werewolf Therapeutics, a biopharmaceutical company pioneering the development of therapeutics to stimulate the body’s immune …
The Intersection of Value and AI: Where Machines Can Make a Difference
Upcoming CCM panel discussion features experts from UPMC, Vanderbilt, NCQA, and Astrata on the future of artificial intelligence in health care